Efficacy of levofloxacin, amoxicillin, bismuth-containing quadruple therapy for helicobacter pylori

被引：0
|
作者：
Huang, Sijing [1 ]
Wang, Chengdang [1 ]
机构：
[1] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
Helicobacter pylori; Drug therapy; Levofloxacin; Bismuth;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：548 / 548
页数：1
相关论文
共 50 条
  • [1] Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for Helicobacter pylori infection
    Bang, Chang Seok
    Lim, Hyun
    Jeong, Hae Min
    Shin, Woon Geon
    Choi, Jae Ho
    Soh, Jae Seung
    Kang, Ho Suk
    Yang, Young Joo
    Hong, Ji Taek
    Shin, Suk Pyo
    Suk, Ki Tae
    Lee, Jae Jun
    Baik, Gwang Ho
    Kim, Dong Joon
    [J]. GUT MICROBES, 2020, 11 (05) : 1314 - 1323
  • [2] Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from China
    Lu, Hong
    Zhang, Wei
    Graham, David Y.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (10) : 1134 - 1140
  • [3] Second line bismuth-containing quadruple therapy for Helicobacter pylori eradication in Korea
    Cho, M.
    Hwang, H.
    Kim, Y.
    Lim, C.
    Oh, J.
    [J]. HELICOBACTER, 2019, 24
  • [4] Evaluating vonoprazan bismuth-containing triple therapy versus quadruple therapy for Helicobacter pylori
    Tang, W-Z
    Li, J-Z
    Liu, T-H
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024,
  • [5] Modified quadruple therapy or bismuth-containing quadruple therapy in the first-line treatment of Helicobacter pylori in Turkey
    Yozgat, Ahmet
    Kasapoglu, Benan
    Demirci, Selim
    Sokmen, Fevzi Coskun
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2021, 113 (07) : 490 - 493
  • [6] HELICOBACTER PYLORI ERADICATION A new, single-capsule bismuth-containing quadruple therapy
    Gisbert, Javier P.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2011, 8 (06) : 307 - 309
  • [7] Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments
    Gisbert, J. P.
    Romano, M.
    Gravina, A. G.
    Solis-Munoz, P.
    Bermejo, F.
    Molina-Infante, J.
    Castro-Fernandez, M.
    Ortuno, J.
    Lucendo, A. J.
    Herranz, M.
    Modolell, I.
    del Castillo, F.
    Gomez, J.
    Barrio, J.
    Velayos, B.
    Gomez, B.
    Dominguez, J. L.
    Miranda, A.
    Martorano, M.
    Algaba, A.
    Pabon, M.
    Angueira, T.
    Fernandez-Salazar, L.
    Federico, A.
    Marin, A. C.
    McNicholl, A. G.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (08) : 768 - 775
  • [8] Efficacy of concomitant non-bismuth quadruple therapy or levofloxacin-containing triple therapy after bismuth containing quadruple therapy failure in clarithromycin-resistant Helicobacter Pylori
    Kim, S.
    Choi, C.
    Kang, D.
    Nam, H.
    Ryu, D.
    [J]. HELICOBACTER, 2016, 21 : 143 - 144
  • [9] Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
    Sung Eun Kim
    Moo In Park
    Seun Ja Park
    Won Moon
    Jae Hyun Kim
    Kyoungwon Jung
    Hae Koo Kim
    Young Dal Lee
    [J]. World Journal of Gastroenterology, 2017, (06) : 1059 - 1066
  • [10] Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori
    Yang, Jing
    Zhang, Yi
    Fan, Ling
    Zhu, Yang-Jie
    Wang, Ting-Yi
    Wang, Xing-Wei
    Chen, Dong-Feng
    Lan, Chun-Hui
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (03): : 437 - 445
12345